The Institute for Pharmacology and Preventive Medicine
The Institute is an experienced partner of universities, non-university institutions, health insurance companies, and pharmaceutical companies in the implementation of scientific projects in the fields of cardiovascular disease and diabetes.
Recent Activity / Publications in press
Thoenes M, Agarwal A, Grundmann D, Ferrero C, McDonald A, Bramlage P, Steeds RP. Narrative review of the role of artificial intelligence to improve aortic valve disease management. J Thorac Dis 2020.
Lawall H, Bramlage P, Gorath M, Wittig T. Intermittent administration of Nitroglycerin sublingual powder compared to placebo in outpatients with peripheral artery disease – results of a randomized proof-of-concept study. Eur J Vasc Endovasc Surg 2020.
Cetinkaya A, Geier A, Bramlage K, Hein S, Bramlage P, Schönburg M, Choi YH, Richter M. Long-Term Results after Mitral Valve Surgery Using Minimally Invasive Versus Sternotomy Approach – a Propensity Matched Comparison of a Large Single-Center Series. BMC Cardiovasc Disorders 2020.
Cetinkaya A, Zeriouh M, Liakopoulose OJ, Hein S, Siemons T, Bramlage P, Schönburg M, Choi YH, Richter M. Minimally invasive left atrial appendage (LAA) clip insertion after challenging LAA occluder implantation to minimize the risk of stroke. J Surg Case Rep 2020.
Sasko B, Patschan D, Nordbeck P, Seidlmayer L, Andresen H, Jänsch M, Bramlage P, Ritter O, Pagonas N. Secondary prevention of potentially life-threatening arrhythmia using implantable cardioverter defibrillators in patients with biopsy-proven viral myocarditis and preserved ejection fraction. Cardiology 2020.
Studencan M, Pella D, Bramlage P, Kaszasova E. Clinical characteristics and management of hyperlipoproteinemia in patients with chronic coronary heart disease in Slovakia. Archives of Medical Science 2020.
PubMed listed Publications